logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/09/2026
Novo Nordisk's chief scientific officer said the company hopes to bring both oral and subcutaneous formulations of Zenagamtide to market.
Latest
3 m ago
Zhengqian Financial Holdings (01152.HK) completed the issuance of 92.126 million consideration shares.
4 m ago
JPMorgan: Aims to establish a $20 billion investment partnership with the Qatar Investment Authority (QIA).
4 m ago
Tianyin Holdings (000829.SZ) plans to list for sale its 100% equity stake in Tianyin Mobile.
4 m ago
Li Auto-W (02015.HK) repurchased 1.2728 million shares for HK$58.2236 million on September 21.
4 m ago
Qushui Technology (301336.SZ) plans to repurchase company shares for RMB 5 million to RMB 10 million.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.